ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 09 Dec 2019
Last Applicant/ Owned by
400 Oyster Point Boulevard, Suite 505
South San Francisco
CA
94080
Serial Number
87009766 filed on 21st Apr 2016
Registration Number
N/A
Correspondent Address
Jennifer Lee Taylor
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BUPLANT
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central ne Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases
Mark Details
Serial Number
No 87009766
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 304146020001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Dec 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 09th Dec 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 04th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 03rd May 2019 | EXTENSION 5 GRANTED |
| 03rd May 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 30th Apr 2019 | TEAS EXTENSION RECEIVED |
| 30th Apr 2019 | EXTENSION 5 FILED |
| 30th Oct 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Oct 2018 | EXTENSION 4 GRANTED |
| 26th Oct 2018 | EXTENSION 4 FILED |